
#Libre – An example of ongoing variance within Diabetes care, looking at London area where this wasn’t supposed to happen…
A review of the variation across London in prescribing Libre.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
A review of the variation across London in prescribing Libre.
If you’ve been looking at Diabetes technology recently, it’s hard not to have seen the recent news from Tandem about rolling out their Predictive Low […]
It’s hard not to have seen the recent Twitter and blog campaign that came about as the result of Grumpy Pumper’s diagnosis of a foot […]
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]
If you’re a person with Type 1 Diabetes, it’s very hard not to have seen the news about Sir Michael Rawlins’ (Chair of the UK […]
If you keep your eyes on Diabetes and medical media, you can’t fail to have noticed that Roche’s Solo Micropump, a new patch pump from […]
Back at the end of March, when Dexcom launched the G6, I questioned how this might affect those using WeAreNotWaiting open source Diabetes technology. It […]
After six months of leaving Fiasp on the shelf, and occasionally using it as an adjunct injection when fast carbs were consumed (where it still […]
Copyright © 2025 | WordPress Theme by MH Themes